|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/09 | |
| C07K 7/06 | |||
| A61K 39/00 |
| (11) | Number of the document | 2553096 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11762265.4 |
| Date of filing the European patent application | 2011-03-30 | |
| (97) | Date of publication of the European application | 2013-02-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2011/001909 |
| Date | 2011-03-30 |
| (87) | Number | WO 2011/122022 |
| Date | 2011-10-06 |
| (30) | Number | Date | Country code |
| 320577 P | 2010-04-02 | US |
| (72) |
NAKAMURA, Yusuke, JP
TSUNODA, Takuya, JP
OHSAWA, Ryuji, JP
YOSHIMURA, Sachiko, JP
WATANABE, Tomohisa, JP
|
| (73) |
Oncotherapy Science, Inc.,
2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012,
JP
|
| (54) | ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |
| ECT2 PEPTIDES AND VACCINES INCLUDING THE SAME |